InterCure Ltd.
INCR · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 0% | 14.9% | 0% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 30.9% | 30.9% | 0.3% | 0.3% |
| EBITDA | $0 | $0 | -$0 | -$0 |
| % Margin | 11% | 11% | -82.5% | -83.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1.3% | -1.3% | -61.2% | -61.2% |
| EPS Diluted | -0.015 | -0.015 | -0.79 | -0.79 |
| % Growth | 0% | 98.1% | 0% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |